IMMUPHARMA PLC Logo

IMMUPHARMA PLC

Specialty biopharmaceutical company developing peptide-based therapeutics.

IMM | IL

Overview

Corporate Details

ISIN(s):
GB0033711010
LEI:
213800VZKGHXC7VUS895
Country:
United Kingdom
Address:
One, EC1A 7BL London

Description

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 08:20
Attending JPMorgan Conference & Biotech Showcase
English HTML 13.1 KB
2025-11-24 08:20
Corporate Update
English HTML 16.2 KB
2025-11-04 08:25
Holding(s) in Company
English HTML 50.5 KB
2025-10-27 08:00
IMMUPHARMA ATTENDING BIO-EUROPE
English HTML 11.4 KB
2025-10-23 08:00
Launch of Website; Corporate Update
English HTML 15.0 KB
2025-10-13 08:00
Appointment of Independent Non-Executive Director
English HTML 16.6 KB
2025-10-06 16:22
Holding(s) in Company
English HTML 52.3 KB
2025-09-17 08:00
Exercise of Warrants
English HTML 14.9 KB
2025-09-11 08:00
Exercise of Warrants
English HTML 14.9 KB
2025-09-01 15:12
Appointments of CSO and Head of R&D
English HTML 15.0 KB
2025-09-01 14:20
ImmuPharma Files New Patent Application for P140:
English HTML 29.6 KB
2025-08-20 14:36
Holding(s) in Company
English HTML 52.0 KB
2025-08-06 08:00
Interim Results
English HTML 324.7 KB
2025-06-12 13:51
Result of AGM
English HTML 19.8 KB
2025-05-27 16:13
Holding(s) in Company
English HTML 52.0 KB

Automate Your Workflow. Get a real-time feed of all IMMUPHARMA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUPHARMA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUPHARMA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.